Shari Annes | Investor Relations |
Brian Hahn | Chief Financial Officer |
Rachel King | Chief Executive Officer |
Helen Thackray | Senior Vice-President, Clinical Development and Chief Medical Officer |
Yatin Suneja | SunTrust Robinson Humphrey |
Jotin Marango | Roth Capital |
Stephen Willey | Stifel |
Biren Amin | Jefferies |
Ritu Baral | Cowen |
Good morning and thank you all for joining GlycoMimetics call. At this time, all participants are in a listen-only mode.
Following management's remarks, we will hold a brief question-and-answer session and at that time, the lines will be opened for you. [Operator Instructions] I would now like to turn the call over to Shari Annes of the Investor Relations Group at GlycoMimetics. Please go ahead.